Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

(2020) Jan Borén et al.   EUROPEAN HEART JOURNAL

Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: A systematic review and meta-analysis

(2020) Damianos G Kokkinidis et al.   VASCULAR MEDICINE

Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome

(2020) Gregory G. Schwartz et al.   CIRCULATION

Rivaroxaban in Peripheral Artery Disease after Revascularization

(2020) Marc P. Bonaca et al.   NEW ENGLAND JOURNAL OF MEDICINE

Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis

(2020) Daniele Pastori et al.   THROMBOSIS AND HAEMOSTASIS

Statin Toxicity

(2019) Natalie C. Ward et al.   CIRCULATION RESEARCH

Six-year survival study after myocardial infarction: The EOLE prospective cohort study. Long-term survival after MI

(2019) Cécile Droz-Perroteau et al.   THERAPIE

Patients with Recent Acute Coronary Syndrome and Polyvascular Disease Derive Large Absolute Benefit from Alirocumab: ODYSSEY OUTCOMES Trial

(2019) J. Wouter Jukema et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Genome-wide association study of peripheral artery disease in the Million Veteran Program

(2019) Derek Klarin et al.   NATURE MEDICINE

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes

(2019) Daniel F. Gudbjartsson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence - Prospective Data from the Women's Health Study

(2018) Aaron W. Aday et al.   CIRCULATION

Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome

(2018) Fredrik Sartipy et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Poor attainment of lipid targets in patients with symptomatic peripheral artery disease

(2018) Jörn F. Dopheide et al.   Journal of Clinical Lipidology

Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease

(2018) Sonia S. Anand et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

(2018) Sonia S Anand et al.   LANCET

Impact of Lipids on Cardiovascular Health

(2018) Brian A. Ference et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pathology of Peripheral Artery Disease in Critical Limb Ischemia

(2018) Navneet Narula et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

(2018) Gregory G. Schwartz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial

(2018) Marc P Bonaca et al.   Lancet Diabetes & Endocrinology

‘Highest risk–highest benefit’ strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies

(2017) Lieven Annemans et al.   EUROPEAN HEART JOURNAL

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

(2017) Brian A. Ference et al.   EUROPEAN HEART JOURNAL

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

(2017) Ulf Landmesser et al.   EUROPEAN HEART JOURNAL

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

(2017) Victor Aboyans et al.   EUROPEAN HEART JOURNAL

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

(2017) Marc S. Sabatine et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

(2017) John W. Eikelboom et al.   NEW ENGLAND JOURNAL OF MEDICINE

Twenty‐Year Predictors of Peripheral Arterial Disease Compared With Coronary Heart Disease in the Scottish Heart Health Extended Cohort (SHHEC)

(2017) Hugh Tunstall‐Pedoe et al.   Journal of the American Heart Association

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease

(2017) Marc P. Bonaca et al.   CIRCULATION

Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan

(2016) Tamio Teramoto et al.   ATHEROSCLEROSIS

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease

(2016) Børge G. Nordestgaard   CIRCULATION RESEARCH

The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis

(2016) Jan Borén et al.   CURRENT OPINION IN LIPIDOLOGY

Follow-up of atheroma burden with sequential whole body contrast enhanced MR angiography: a feasibility study

(2016) Jonathan R. Weir-McCall et al.   INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING

Statins for Prevention of Cardiovascular Events in a Low-Risk Population With Low Ankle Brachial Index

(2016) Rafel Ramos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease

(2016) Marc P. Bonaca et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease

(2016) Anna Franzone et al.   JAMA Cardiology

Systemic inflammation is higher in peripheral artery disease than in stable coronary artery disease

(2015) Philipp Rein et al.   ATHEROSCLEROSIS

Epidemiology of Peripheral Artery Disease

(2015) M. H. Criqui et al.   CIRCULATION RESEARCH

Prevalence of type 2 diabetes is higher in peripheral artery disease than in coronary artery disease patients

(2015) Guenther Silbernagel et al.   Diabetes & Vascular Disease Research

Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence

(2015) H. Reinecke et al.   EUROPEAN HEART JOURNAL

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

(2015) Erik S. Stroes et al.   EUROPEAN HEART JOURNAL

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

(2015) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Discontinuation of Statins in Routine Care Settings

(2013) Huabing Zhang et al.   ANNALS OF INTERNAL MEDICINE

Vorapaxar in Patients With Peripheral Artery Disease

(2013) Marc P. Bonaca et al.   CIRCULATION

Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences

(2013) Rajiv Chowdhury et al.   EUROPEAN HEART JOURNAL

Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis

(2013) F Gerald R Fowkes et al.   LANCET

The influence of atorvastatin on walking performance in peripheral arterial disease

(2013) Bregar et al.   Vasa-European Journal of Vascular Medicine

Effect of Statins on Skeletal Muscle Function

(2012) Beth A. Parker et al.   CIRCULATION

Associations Between Conventional Cardiovascular Risk Factors and Risk of Peripheral Artery Disease in Men

(2012) Michel M. Joosten et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users

(2012) Jerome D. Cohen et al.   Journal of Clinical Lipidology

Lipoprotein subfractions and cardiovascular disease risk

(2010) Ronald M Krauss   CURRENT OPINION IN LIPIDOLOGY

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial

(2010) Jill J.F. Belch et al.   JOURNAL OF VASCULAR SURGERY

Patients with peripheral arterial disease in the CHARISMA trial

(2009) P. P. Cacoub et al.   EUROPEAN HEART JOURNAL

Drug Therapy for Improving Walking Distance in Intermittent Claudication: A Systematic Review and Meta-analysis of Robust Randomised Controlled Studies

(2009) A.H. Momsen et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease

(2009) Jeffrey S. Berger et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Increased apoB/apoA-I Ratio Is Predictive of Peripheral Arterial Disease in Initially Healthy 58-Year-old Men During 8.9 Years of Follow-up

(2008) L. Johansson et al.   ANGIOLOGY

Long-Term Prognosis of Patients With Peripheral Arterial Disease

(2008) Gijs M.J.M. Welten et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease

(2007) Manfredi Rizzo et al.   ATHEROSCLEROSIS